Sonawane
Kiran Babasaheb Sonawane, Pune IN
Patent application number | Description | Published |
---|---|---|
20140309182 | INSECTICIDAL COMPOUNDS FROM NOTHAPODITES FOETIDA AND PROCESS FOR THE EXTRACTION THEREOF - The present invention relates to an insecticidal enriched extract (biopesticide) isolated from the stem of | 10-16-2014 |
Milind Sonawane, Syracuse, CA US
Patent application number | Description | Published |
---|---|---|
20150100840 | SCAN SYSTEMS AND METHODS - Efficient scan system presented can comprise: an array including a plurality of array non scannable components and a plurality of array quasi-scannable components wherein each column of the array includes at least one of the plurality of array quasi-scannable components; and an input interface configured to receive and selectively forward data and scan information to at least a portion of the array. At least a portion of the plurality of array quasi-scannable components can form a diagonal pattern in the array. The input interface can include: an input interface selection component wherein an output of the input interface selection component is communicatively coupled to an input of the input interface quasi-scannable component associated with one row and an input of the input interface selection component is communicatively coupled to an output of one of the plurality of array quasi-scannable components associated with another row. | 04-09-2015 |
Milind Sonawane, San Jose, CA US
Patent application number | Description | Published |
---|---|---|
20140189452 | SYSTEM FOR REDUCING PEAK POWER DURING SCAN SHIFT AT THE LOCAL LEVEL FOR SCAN BASED TESTS - A method for performing scan based tests is presented. The method comprises routing scan data serially from a plurality of I/O ports to a plurality of partitions of an integrated circuit using a first clock signal operating at a first frequency, wherein each partition comprises a plurality of internal scan chains. The method also comprises deserializing the scan data to feed internal scan chains. Further, the method comprises generating a plurality of second clock signals operating at a second frequency using the first clock signal, wherein each partition receives a respective one of the plurality of second clock signals and wherein the plurality of second clock signals are staggered wherein each pulses at a different time. Finally, the method comprises shifting in the scan data into the internal scan chains at the rate of the second frequency. | 07-03-2014 |
20140189454 | GLOBAL LOW POWER CAPTURE SCHEME FOR CORES - A method for testing an integrated circuit to reduce peak power problems during scan capture mode is presented. The method comprises programming a respective duration of a first time window for each of a plurality of cores and a cache on the integrated circuit. It further comprises counting the number of pulses of a first clock signal during the first time window for each of the plurality of cores and the cache. Subsequently, the method comprises staggering capture pulses to the plurality of cores and the cache by generating pulses of a second clock signal for each of the plurality of cores and the cache during a respective second time window, wherein the number of pulses generated is based on the respective number of first clock signal pulses counted for each of the plurality of cores and the cache. | 07-03-2014 |
20140189455 | SYSTEM FOR REDUCING PEAK POWER DURING SCAN SHIFT AT THE GLOBAL LEVEL FOR SCAN BASED TESTS - A method for reducing peak power during a scan shift cycle is presented. The method comprises multiplexing a test clock with a functional clock on a integrated circuit at the root of a clock tree. The method also comprises adding a plurality of delay elements on a clock path, wherein the clock path is a signal resulting from the multiplexing. Further, the method comprises routing the clock path to a plurality of cores and a cache, e.g., an L2C cache, on the integrated circuit. Finally the method comprises staggering the test clock received by each of the plurality of cores and the cache by employing the delay elements during a scan shift cycle. | 07-03-2014 |
Navneet Sonawane, Mumbai IN
Patent application number | Description | Published |
---|---|---|
20110206788 | NOVEL HERBAL COMPOSITION - Disclosed herein is synergistic herbal composition comprising extracts of herbal ingredients of | 08-25-2011 |
20140294998 | NOVEL HERBAL COMPOSITION - Disclosed herein is synergistic herbal composition comprising extracts of herbal ingredients of | 10-02-2014 |
Nitin Sonawane, Littleton, MA US
Patent application number | Description | Published |
---|---|---|
20090083803 | System and method for receiving broadcast multimedia on a mobile device - A system and a method receive broadcast multimedia on a mobile device. The system and the method may use a broadcast receiver accessory that may connect to a mobile device. The system and the method may have a bidirectional data connection between the broadcast receiver accessory and the mobile device. The broadcast receiver accessory may translate, reformat and/or repackage content into a form that may be viewed on the mobile device. The broadcast receiver accessory may have a tuner component, an application processor, an audio rendering element and/or memory. | 03-26-2009 |
Nitin D. Sonawane, San Francisco, CA US
Patent application number | Description | Published |
---|---|---|
20090253799 | DIVALENT HYDRAZIDE COMPOUND CONJUGATES FOR INHIBITING CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR - Provided herein are divalent hydrazide-polyethylene glycol conjugates that inhibit the ion transport activity of a cystic fibrosis transmembrane conductance regulator (CFTR). The conjugates described herein are useful for treating diseases, disorders, and sequelae of diseases, disorders, and conditions that are associated with aberrantly increased CFTR activity, for example, secretory diarrhea. | 10-08-2009 |
20110105565 | WATER SOLUBLE SMALL MOLECULE INHIBITORS OF THE CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR - Provided herein are highly water soluble, thiazolidinone derivative compounds and glycine hydrazide derivative compounds that inhibit the ion transport activity of the cystic fibrosis transmembrane conductance regulator (CFTR). The compounds, and compositions comprising the compounds, described herein are useful for treating diseases, disorders, and sequelae of diseases, disorders, and conditions that are associated with aberrantly increased CFTR activity, for example, secretory diarrhea. The compounds may also be used for inhibiting expansion or preventing formation of cysts in persons who have polycystic kidney disease. | 05-05-2011 |
Nitin Dattatraya Sonawane, San Francisco, CA US
Patent application number | Description | Published |
---|---|---|
20090048207 | HYDRAZIDE-CONTAINING CFTR INHIBITOR COMPOUNDS AND USES THEREOF - The invention provides compositions, pharmaceutical preparations and methods for inhibition of cystic fibrosis transmembrane conductance regulator protein (CFTR) that are useful for the study and treatment of CFTR-mediated diseases and conditions. The compositions and pharmaceutical preparations of the invention may comprise one or more hydrazide-containing compounds, and may additionally comprise one or more pharmaceutically acceptable carriers, excipients and/or adjuvants. The methods of the invention comprise, in certain embodiments, administering to a patient suffering from a CFTR-mediated disease or condition, an efficacious amount of a hydrazide-containing compound. In other embodiments the invention provides methods of inhibiting CFTR that comprise contacting cells in a subject with an effective amount of a hydrazide-containing compound. In addition, the invention features a non-human animal model of CFTR-mediated disease which model is produced by administration of a hydrazide-containing compound to a non-human animal in an amount sufficient to inhibit CFTR. | 02-19-2009 |
20110119775 | HYDRAZIDE-CONTAINING CFTR INHIBITOR COMPOUNDS AND USES THEREOF - The invention provides compositions, pharmaceutical preparations and methods for inhibition of cystic fibrosis transmembrane conductance regulator protein (CFTR) that are useful for the study and treatment of CFTR-mediated diseases and conditions. The compositions and pharmaceutical preparations of the invention may comprise one or more hydrazide-containing compounds, and may additionally comprise one or more pharmaceutically acceptable carriers, excipients and/or adjuvants. The methods of the invention comprise, in certain embodiments, administering to a patient suffering from a CFTR-mediated disease or condition, an efficacious amount of a hydrazide-containing compound. In other embodiments the invention provides methods of inhibiting CFTR that comprise contacting cells in a subject with an effective amount of a hydrazide-containing compound. In addition, the invention features a non-human animal model of CFTR-mediated disease which model is produced by administration of a hydrazide-containing compound to a non-human animal in an amount sufficient to inhibit CFTR. | 05-19-2011 |
Pankaj Sonawane, Mumbai IN
Patent application number | Description | Published |
---|---|---|
20120085725 | CHILD RESISTANT SCREW CAP - The present invention relates to a child resistant cap assembly having an outer cap and an inner cap assembly that is difficult to be opened by children, and at the same time is simple and easy to use by adults. At the time of locking, the outer cap block and the inner cap block is stuck and after locking, are immovable. The cap is difficult to open by children. To open the cap, one must push the outer cap down and then turn the cap. The child resistant cap assembly has an outer cap, an inner cap assembly that is difficult to be opened by children and at the same time is simple and easy to use by a grownup. The child resistant cap assembly has an outer cap and an inner cap assembly that is difficult to be opened by children and at the same time is simple and easy to use by a grownup. | 04-12-2012 |
Ravindra Sonawane, Ilhas, Goa IN
Patent application number | Description | Published |
---|---|---|
20160066574 | Herbicidal Compounds - The invention relates to pyrrolone compounds of the formula (I) wherein X, R | 03-10-2016 |
Ravindra Sonawane, Goa IN
Patent application number | Description | Published |
---|---|---|
20140243371 | MICROBIOCIDAL PYRAZOLE DERIVATIVES - The present invention relates to compounds of formula (I) wherein R | 08-28-2014 |
20150031541 | MICROBIOCIDAL PYRAZOLE DERIVATIVES - Compounds of the formula (I) wherein the substituents are as defined in claim | 01-29-2015 |
Ravindra S. Sonawane, Pune IN
Patent application number | Description | Published |
---|---|---|
20150287485 | X-RAY SHIELDING MATERIAL AND METHOD OF PREPARATION THEREOF - The present disclosure relates to a process for synthesis of barium bismuth sulfide nanofibers, having equivalent shielding capacity as lead. The present disclosure also relates to a radiation shielding articles and cosmeceuticals. | 10-08-2015 |
Ravindra Shravan Sonawane, Pune IN
Patent application number | Description | Published |
---|---|---|
20140170088 | BARIUM ZIRCONIUM OXIDE (BaZrO3.BaCO3) NANOPARTICLES - The present disclosure provides nanoparticles of barium zirconium oxide (BaZrO | 06-19-2014 |
Sagar Shashikant Sonawane, Pune IN
Patent application number | Description | Published |
---|---|---|
20150269386 | SYSTEMS AND METHODS FOR INCREASING COMPLIANCE WITH DATA LOSS PREVENTION POLICIES - A computer-implemented method for increasing compliance with data loss prevention policies may include (1) identifying a file that is subject to a data loss prevention policy, (2) determining a classification of the file according to the data loss prevention policy, (3) identifying a graphical user interface that is configured to display a representation of the file, and (4) enhancing the representation of the file within the graphical user interface with a visual indication of the classification of the file according to the data loss prevention policy. Various other methods, systems, and computer-readable media are also disclosed. | 09-24-2015 |
Sandeep Sonawane, Maharashtra IN
Patent application number | Description | Published |
---|---|---|
20090306170 | SYNTHESIS OF TEGASEROD OR A SALT THEREOF - The present invention relates to a novel process for the synthesis of 1-((5-methoxy-1H-indol-3-yl)methyleneamino)-3-pentyl-guanidine, commonly known as tegaserod, which is used as a gastroprokinetic, and salts thereof. The present invention also relates to tegaserod and salts thereof having an HPLC purity of about 95% or more. The present invention further relates to pharmaceutical compositions comprising tegaserod or a salt thereof, second medical uses of tegaserod or a salt thereof, and methods of treating or preventing irritable bowel syndrome using tegaserod or a salt thereof. | 12-10-2009 |
20100249162 | PROCESS FOR THE INTRODUCTION OF HYDROXYETHOXY SIDE CHAIN IN BOSENTAN - The present invention relates to an improved process for the preparation of bosentan. In particular it relates to a process for preparing bosentan substantially free from the dimer impurity of formula (II) and the 6-hydroxy impurity of formula (III). The invention also relates to a pharmaceutical composition comprising bosentan and its use in the treatment of endothelin-receptor mediated disorders. | 09-30-2010 |
20110184071 | PROCESS FOR THE PREPARATION OF AMINES - The present invention relates to an improved process for the preparation of rasagiline (1) and its pharmaceutically acceptable salts. In particular it relates to a process for preparing rasagiline (1) and its salts substantially free from impurities. | 07-28-2011 |
20110251288 | PROCESS FOR THE PREPARATION OF ENANTIOMERICALLY PURE AMINES - The present invention relates to an improved process for the preparation of (R)-1-aminoindan (2), rasagiline (1) and pharmaceutically acceptable salts of rasagiline. | 10-13-2011 |
20110263719 | POLYMORPHIC FORM OF RASAGILINE MESYLATE - The present invention relates to a novel crystalline form of rasagiline mesylate and a pure form of rasagiline mesylate and processes for their preparation. Further, the invention relates to pharmaceutical compositions comprising said forms and use of said compositions in the treatment of patients suffering from Parkinson's Disease, dementia, Alzheimer's Disease, depression, hyperactive syndrome, stroke, brain ischemia, neurotrauma, schizophrenia and multiple sclerosis. | 10-27-2011 |
20130303741 | PROCESS FOR THE PREPARATION OF ENANTIOMERICALLY PURE AMINES - The present invention relates to an improved process for the preparation of (R)-1-aminoindan (2), rasagiline (1) and pharmaceutically acceptable salts of rasagiline. | 11-14-2013 |
Sandip Sonawane, Bangalore IN
Patent application number | Description | Published |
---|---|---|
20110123610 | EXTENDED RELEASE COMPOSITIONS CONTAINING TOLTERODINE AND PROCESS FOR PREPARING THE SAME - The present invention is directed to an extended release pharmaceutical composition such as tablets and capsules, and in particular to a matrix tablet composition comprising a therapeutically effective quantity of Tolterodine or pharmaceutical acceptable salts thereof incorporated in a hydrophobic matrix comprising water insoluble polymer and wax and a method for the preparation thereof. | 05-26-2011 |
Shailendra Sonawane, Mumbai IN
Patent application number | Description | Published |
---|---|---|
20150080312 | HEXADEPSIPEPTIDE ANALOGUES AS ANTICANCER COMPOUNDS - This invention relates to an isolated, compound of Formula (1) | 03-19-2015 |
Swapnil Laxman Sonawane, Pune IN
Patent application number | Description | Published |
---|---|---|
20150183956 | HIGHLY FLUORESCENT MONODISPERSE, CROSS-LINKED POLYMER MICROBEADS - The invention disclosed herein is the composition comprising a fluorescent chromophore as cross linker incorporated to polymer beads, wherein the fluorescence of the composition occurs in solid state and solution state with high quantum yield in solid state. Particularly, the invention provides fluorescent monodisperse crosslinked PS-PBIX, PS-OPVX, PS-PBITEGA, PS-PBITEGA-OPVX, PS-PBIX-OPVX, PMMA-OPVX, and PMMA-PBIX microspheres or beads, having tunable color emission such that fluorophore made using PS-PBITEGA-OPVX will emit white light. Further it discloses process for the preparation of highly fluorescent monodisperse, cross-linked polymer microbeads. | 07-02-2015 |
Swapnil P. Sonawane, Pune IN
Patent application number | Description | Published |
---|---|---|
20110105598 | Process for Preparation of Taxane Derivatives - The present disclosure relates to processes for the preparation of taxane derivatives with improved purity and enhanced stability. The taxane derivatives prepared according to the processes described herein are useful for the preparation of pharmaceutical compositions. | 05-05-2011 |
Swapnil Panditrao Sonawane, Pune IN
Patent application number | Description | Published |
---|---|---|
20150045554 | SYNTHESIS OF RALTEGRAVIR - The present invention relates to a novel synthetic route for the preparation of raltegravir and pharmaceutically acceptable salts, starting from 2-amino-2-methylpropanenitrile and oxadiazole carbonyl chloride, through the formation of a pyrimidinone intermediate of formula (V). | 02-12-2015 |
Swapnil Panditrao Sonawane, Maharashtra IN
Patent application number | Description | Published |
---|---|---|
20080269508 | Method for Manufacture of 4-Hydroxy Pyran-2-One Derivatives - A process for preparation of 4-hydroxy-pyran-2-one derivative of formula (I), | 10-30-2008 |
Vijay Sonawane, Pune IN
Patent application number | Description | Published |
---|---|---|
20120006297 | COMMON RAIL SYSTEM WITH LEAK CONTAINMENT AND DETECTION - This disclosure provides a fuel system for supplying fuel to an internal combustion engine, an internal combustion engine that includes such a fuel system, a connector for connecting a single-walled high pressure common rail to a double-walled fuel line segment, and a fluid containment system. Each embodiment includes drain plumbing having a leakage drain connector that can be used to provide an interface between a single-walled high pressure common rail and a double-walled high pressure fuel line segment, and also provide part of a low pressure passage fluidly connected with a low pressure passage of the double-walled high pressure fuel line segment. The drain plumbing also can provide an interface with a low pressure fuel drain line fluidly coupled to a leakage detector. | 01-12-2012 |
20120006299 | ASSEMBLY FOR CONNECTING DOUBLE HIGH PRESSURE WALL LINE TO A SINGLE-WALLED HIGH PRESSURE CONNECTOR - This disclosure provides a fuel line assembly for use with an internal combustion engine, an internal combustion engine including such as fuel line assembly, and a method for providing leak containment and detection in a fuel system, each of which include a double-walled fuel line including a high pressure fuel line component. The double-walled fuel line includes a high pressure fuel line, a jacket surrounding the high pressure fuel line, and a low pressure passage between the high pressure fuel line and the jacket. A fuel line nut includes a main body that houses a portion of the high pressure fuel line, and a first end portion supporting an enlarged end portion of the high pressure fuel line protruding from the first end portion. A second end portion of the fuel line nut sealingly connects to the jacket to extend the low pressure passage into an area between the main body and the housed high pressure fuel line. A fuel line connector mechanically and sealingly engages with the fuel line nut to house the supported enlarged end portion of the high pressure fuel line. The fuel line connector can connect to a single-walled high pressure tube provided in a bore of the cylinder head between an inlet of a fuel injector and the environment exterior of the cylinder head. | 01-12-2012 |